{"id":"https://openalex.org/W2108026478","doi":"https://doi.org/10.1158/2326-6066.cir-14-0039","title":"Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape","display_name":"Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape","publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W2108026478","doi":"https://doi.org/10.1158/2326-6066.cir-14-0039","mag":"2108026478","pmid":"https://pubmed.ncbi.nlm.nih.gov/24795351"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-14-0039","doi":"https://doi.org/10.1158/2326-6066.cir-14-0039","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-14-0039","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088775441","display_name":"Ana Carrizosa Anderson","orcid":"https://orcid.org/0000-0002-0877-2932","observed_orcids":["https://orcid.org/0000-0002-0877-2932"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ana C. Anderson","raw_affiliation_strings":["Author's Affiliation: Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Author's Affiliation: Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088775441"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":3.3628,"has_fulltext":false,"cited_by_count":307,"citation_normalized_percentile":{"value":0.95905551,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"2","issue":"5","first_page":"393","last_page":"398"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.9909999966621399},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7839999794960022},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/immune-checkpoint-receptors","display_name":"immune checkpoint receptors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.8600000143051147},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":1.0},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6000000238418579},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8539999723434448},{"id":"https://openalex.org/keywords/kidney-cancer","display_name":"kidney cancer","score":0.9259999990463257},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.7895662784576416},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.7726401090621948},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6994613409042358},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6767150163650513},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6626555323600769},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6590505838394165},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.557749330997467},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5338543653488159},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5207476615905762},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.4855460822582245},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.47098466753959656},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4576001465320587},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4366302490234375},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4144865870475769},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3068996071815491},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.23962831497192383},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21401044726371765},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21247336268424988}],"mesh":[{"descriptor_ui":"D000072597","descriptor_name":"Hepatitis A Virus Cellular Receptor 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/2326-6066.cir-14-0039","doi":"https://doi.org/10.1158/2326-6066.cir-14-0039","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-14-0039","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:24795351","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24795351","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.859.3798","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.859.3798","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerimmunolres.aacrjournals.org/content/2/5/393.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1856206988","https://openalex.org/W1968791512","https://openalex.org/W1971425687","https://openalex.org/W1976105607","https://openalex.org/W1994257755","https://openalex.org/W2006445674","https://openalex.org/W2013177587","https://openalex.org/W2015085911","https://openalex.org/W2021379322","https://openalex.org/W2028824678","https://openalex.org/W2031627869","https://openalex.org/W2041544510","https://openalex.org/W2050558251","https://openalex.org/W2056211666","https://openalex.org/W2056535502","https://openalex.org/W2070631889","https://openalex.org/W2076067786","https://openalex.org/W2077450385","https://openalex.org/W2097995306","https://openalex.org/W2101581360","https://openalex.org/W2107598346","https://openalex.org/W2112123471","https://openalex.org/W2112400160","https://openalex.org/W2114238926","https://openalex.org/W2118982164","https://openalex.org/W2119896120","https://openalex.org/W2121080857","https://openalex.org/W2144373841","https://openalex.org/W2145476394","https://openalex.org/W2149121521","https://openalex.org/W2151293773","https://openalex.org/W2151328705","https://openalex.org/W2160834915","https://openalex.org/W2168231169","https://openalex.org/W2172223853"],"related_works":["https://openalex.org/W7100584520","https://openalex.org/W2593059553","https://openalex.org/W2897230620","https://openalex.org/W3037333252","https://openalex.org/W4417151448","https://openalex.org/W2596120176","https://openalex.org/W4241985391","https://openalex.org/W3170205430","https://openalex.org/W3031526322","https://openalex.org/W4385760390"],"abstract_inverted_index":{"The":[0],"cancer":[1],"immunotherapy":[2],"field":[3],"has":[4,77],"grown":[5],"exponentially":[6],"in":[7,34,80,128],"the":[8,15,23,87,91,103,119],"past":[9],"few":[10],"years,":[11],"largely":[12,67],"driven":[13],"by":[14],"success":[16],"of":[17,45,89,94,122],"immune":[18,24,83,104,126],"checkpoint":[19,25,84,95,105],"blockade.":[20],"Therapies":[21],"targeting":[22,81],"molecules":[26],"CTLA-4":[27,73],"and":[28,38,74],"PD-1":[29],"have":[30,63],"achieved":[31],"objective":[32],"responses":[33],"melanoma,":[35],"renal":[36],"cancer,":[37],"lung":[39],"cancer;":[40],"however,":[41],"a":[42],"large":[43],"number":[44],"patients":[46],"are":[47,54],"still":[48],"suffering":[49],"with":[50,86],"these":[51,58],"cancers":[52,62],"that":[53,71,112,124],"not":[55],"benefiting":[56],"from":[57],"therapies.":[59],"Moreover,":[60],"several":[61,109],"proved":[64],"to":[65,69],"be":[66],"refractory":[68],"therapies":[70,123],"target":[72,125],"PD-1.":[75],"This":[76],"catalyzed":[78],"interest":[79],"novel":[82],"receptors":[85],"goal":[88],"realizing":[90],"full":[92],"potential":[93],"blockade":[96],"for":[97,118],"treating":[98],"cancer.":[99,129],"In":[100],"this":[101],"regard,":[102],"receptor":[106],"Tim-3":[107],"exhibits":[108],"unique":[110],"features":[111],"make":[113],"it":[114],"an":[115],"intriguing":[116],"candidate":[117],"next":[120],"wave":[121],"checkpoints":[127]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":27},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":40},{"year":2020,"cited_by_count":36},{"year":2019,"cited_by_count":39},{"year":2018,"cited_by_count":33},{"year":2017,"cited_by_count":32},{"year":2016,"cited_by_count":30},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}